Ultrasound-targeted ablation of the aortorenal ganglion significantly reduces blood pressure and suppresses sympathetic nerve activity in a canine model of hypertension.
Does ultrasound-targeted ablation of the aortorenal ganglion reduce blood pressure and alleviate ventricular remodeling in a canine model of hypertension?
Ultrasound-targeted ablation of the aortorenal ganglion demonstrates preclinical promise as a therapeutic strategy for hypertension by reducing blood pressure and sympathetic nerve activity.
Absolute Event Rate: 0% vs 0%
Ultrasound-targeted ablation of the ARG significantly reduces blood pressure, suppresses sympathetic nerve activity in the systemic, cardiac, and renal regions, and alleviates hypertension-induced ventricular remodeling, offering a promising therapeutic strategy for hypertension and related cardiovascular diseases.
Li et al. (Wed,) reported a other. Ultrasound-targeted ablation of the aortorenal ganglion significantly reduces blood pressure and suppresses sympathetic nerve activity in a canine model of hypertension.